A pilot study examining the efficacy of Keppra [levetiracetam] in acute alcohol related seizure control in the emergency department setting.
Withdrawn prior to enrolment
Phase of Trial: Phase II
Latest Information Update: 12 Jun 2018
At a glance
- Drugs Levetiracetam (Primary)
- Indications Seizures
- Focus Therapeutic Use
- 05 Jun 2018 Planned primary completion date changed from 1 Jul 2008 to 2 Feb 2008.
- 05 Jun 2018 Status changed from not yet recruiting to withdrawn prior to enrolment.
- 16 Oct 2009 UCB added as sponsor as reported by ClinicalTrials.gov.